Fusobacterium nucleatum drives a pro-inflammatory intestinal microenvironment through metabolite receptor-dependent modulation of IL-17 expression.
Fusobacterium nucleatum drives a pro-inflammatory intestinal microenvironment through metabolite receptor-dependent modulation of IL-17 expression.
复制标题
DOI:
10.1080/19490976.2021.1987780
复制
发表时间:
2021-01
期刊:
影响因子:
12.2
通讯作者:
Garrett WS
中科院分区:
文献类型:
--
作者:
Brennan CA;Clay SL;Lavoie SL;Bae S;Lang JK;Fonseca-Pereira D;Rosinski KG;Ou N;Glickman JN;Garrett WS
The colorectal cancer (CRC)-associated microbiota creates a pro-tumorigenic intestinal milieu and shapes immune responses within the tumor microenvironment. However, how oncomicrobes – like Fusobacterium nucleatum, found in the oral cavity and associated with CRC tissues– affect these distinct aspects of tumorigenesis is difficult to parse. Herein, we found that neonatal inoculation of ApcMin/+ mice with F. nucleatum strain Fn7-1 circumvents technical barriers preventing its intestinal colonization, drives colonic Il17a expression prior to tumor formation, and potentiates intestinal tumorigenesis. Using gnotobiotic mice colonized with a minimal complexity microbiota (the altered Schaedler’s flora), we observed that intestinal Fn7-1 colonization increases colonic Th17 cell frequency and their IL-17A and IL-17F expression, along with a concurrent increase in colonic lamina propria Il23p19 expression. As Fn7-1 stably colonizes the intestinal tract in our models, we posited that microbial metabolites, specifically short-chain fatty acids (SCFA) that F. nucleatum abundantly produces in culture and, as we demonstrate, in the intestinal tract, might mediate part of its immunomodulatory effects in vivo. Supporting this hypothesis, we found that Fn7-1 did not alter RORγt+ CD4+T cell frequency in the absence of the SCFA receptor FFAR2. Taken together, our work suggests that F. nucleatum influences intestinal immunity by shaping Th17 responses in an FFAR2-dependent manner, although further studies are necessary to clarify the precise and multifaceted roles of FFAR2. The potential to increase intestinal Th17 responses is shared by another oncomicrobe, enterotoxigenic Bacteroides fragilis, highlighting a conserved pathway that could potentially be targeted to slow oncomicrobe-mediated CRC.
登录
查看更多内容
影响因子:
28.2
作者:
Donohoe DR;Holley D;Collins LB;Montgomery SA;Whitmore AC;Hillhouse A;Curry KP;Renner SW;Greenwalt A;Ryan EP;Godfrey V;Heise MT;Threadgill DS;Han A;Swenberg JA;Threadgill DW;Bultman SJ
通讯作者:
Bultman SJ
影响因子:
6.4
作者:
Engevik MA;Danhof HA;Ruan W;Engevik AC;Chang-Graham AL;Engevik KA;Shi Z;Zhao Y;Brand CK;Krystofiak ES;Venable S;Liu X;Hirschi KD;Hyser JM;Spinler JK;Britton RA;Versalovic J
通讯作者:
Versalovic J
影响因子:
32.4
作者:
Chun, Eunyoung;Lavoie, Sydney;Garrett, Wendy S.
通讯作者:
Garrett, Wendy S.
影响因子:
7
作者:
Castellarin, Mauro;Warren, Rene L.;Holt, Robert A.
通讯作者:
Holt, Robert A.
影响因子:
11.2
作者:
Housseau F;Wu S;Wick EC;Fan H;Wu X;Llosa NJ;Smith KN;Tam A;Ganguly S;Wanyiri JW;Iyadorai T;Malik AA;Roslani AC;Vadivelu JS;Van Meerbeke S;Huso DL;Pardoll DM;Sears CL
通讯作者:
Sears CL